Literature DB >> 188566

Elevated serum and spleen angiotensin converting enzyme and serum lysozyme in Gaucher's disease.

E Silverstein, J Friedland.   

Abstract

In adult chronic non-neuronopathic (Type 1) Gaucher's disease significant (p less than 0.001) elevations of angiotensin converting enzyme in serum (93.3 +/- 14.8 nmol/min/ml; number elevated, 8/11; normal control 32.2 +/- 1.30, n = 58) and spleen (5.62 +/- 0.35 nmol/min/mg protein, n = 2; control, 0.431 +/- 0.101, n = 4) and serum lysozyme (15.6 +/- 3.37 mug/ml; number elevated, 4/5) were observed. The KM for hippuryl-L-histidyl-L-leucine of Gaucher (1.31 mM) and normal (1.23 mM) serum angiotensin converting enzyme were similar. The increased angiotensin converting enzyme (ACE) in Gaucher's disease may be related to the genetic defect resulting in increased ACE synthesis in Gaucher cells, or perhaps generally, while high lysozyme may reflect an increased body mass of reticuloendothelial cells. These enzyme elevations may be of use in suggesting the possible presence of Gaucher's disease and perhaps in assessing the magnitude of pathologic involvement.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 188566     DOI: 10.1016/0009-8981(77)90382-5

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  11 in total

1.  Marked increase of methylumbelliferyl-tetra-N-acetylchitotetraoside hydrolase activity in plasma from Gaucher disease patients.

Authors:  W R den Tandt; F van Hoof
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

2.  ACE phenotyping in Gaucher disease.

Authors:  Sergei M Danilov; Victoria E Tikhomirova; Roman Metzger; Irina A Naperova; Tatiana M Bukina; Ozlem Goker-Alpan; Nahid Tayebi; Nurshat M Gayfullin; David E Schwartz; Larisa M Samokhodskaya; Olga A Kost; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2018-02-17       Impact factor: 4.797

3.  Immunofluorescent localization of angiotensin converting enzyme in epithelioid and giant cells of sarcoidosis granulomas.

Authors:  E Silverstein; L P Pertschuk; J Friedland
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

4.  An ACE diagnosis.

Authors:  Omar Nasher; Anindya Gupta
Journal:  BMJ Case Rep       Date:  2013-02-14

Review 5.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

6.  Effect of SQ 14225, an inhibitor of angiotensin I-converting enzyme, on the granulomatous response to Schistosoma mansoni eggs in mice.

Authors:  J V Weinstock; M N Ehrinpreis; D L Boros; J B Gee
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

7.  Human lung angiotensin converting enzyme. Purification and antibody preparation.

Authors:  J Friedland; E Silverstein; M Drooker; C Setton
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

8.  Role of angiotensin-converting enzyme in Bacille Calmette-Guérin-induced granulomatous inflammation. Increased angiotensin-converting enzyme levels in lung lavage and suppression of inflammation with captopril.

Authors:  D J Schrier; L M Ripani; A L Katzenstein; V L Moore
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

9.  Genomic expression analyses reveal lysosomal, innate immunity proteins, as disease correlates in murine models of a lysosomal storage disorder.

Authors:  Md Suhail Alam; Michelle Getz; Innocent Safeukui; Sue Yi; Pamela Tamez; Jenny Shin; Peter Velázquez; Kasturi Haldar
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

10.  The changes of serum-ACE, plasma renin activity and aldosterone in the diabetics with hypertension.

Authors:  J K Oh; I K Han; J W Kim; Y S Kim; K S Cho; K W Kim; S W Kim; Y K Choi
Journal:  Korean J Intern Med       Date:  1986-01       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.